Oxysterols and neurodegenerative diseases
In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess...
Gespeichert in:
Veröffentlicht in: | Molecular aspects of medicine 2009-06, Vol.30 (3), p.171-179 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 179 |
---|---|
container_issue | 3 |
container_start_page | 171 |
container_title | Molecular aspects of medicine |
container_volume | 30 |
creator | Björkhem, Ingemar Cedazo-Minguez, Angel Leoni, Valerio Meaney, Steve |
description | In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain. The opposite flux of 27-hydroxycholesterol (27-OHC) from the circulation into the brain may regulate a number of key enzymes within the brain.
In vitro experiments suggest that the balance between the levels of these two molecules may be of importance for the generation of β-amyloid peptides. In primary cultures of rat hippocampal cells 27-OHC is able to suppress expression of the activity regulated cytoskeleton-associated protein (Arc), a protein important in memory consolidation which is reduced in patients with Alzheimer’s disease (AD). In the present work we explore the possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia, and discuss the possibility that modification of this flux may be a therapeutic strategy. Lastly, we discuss the use of oxysterols as diagnostic markers in neurodegenerative disease. |
doi_str_mv | 10.1016/j.mam.2009.02.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_559428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0098299709000089</els_id><sourcerecordid>67272916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-5170c2a9f7575fdeb2a43f36c57709d3d244176888501d816d4a840a7691e17a3</originalsourceid><addsrcrecordid>eNp9kctKxDAUhoMoOl4ewI3MSnDRmpPmiisRbyC40XXINKeScdqOSevl7Y3MqCtdJSTfd0L-n5BDoCVQkKfzsnVtySg1JWUlpbBBJqAVKwwXbJNM8oUumDFqh-ymNM-AUFJskx0wjGtNqwk5uX__SAPGfpGmrvPTDsfYe3zCDqMbwitOfUjoEqZ9stW4RcKD9bpHHq8uHy5uirv769uL87ui5pUZCgGK1syZRgklGo8z5njVVLIWSlHjK884ByW11oKC1yA9d5pTp6QBBOWqPVKs5qY3XI4zu4yhdfHD9i7Y9dFz3qEVwnCmM2_-5Jf5L7_Stwigs1lJk93jlZvBlxHTYNuQalwsXIf9mKxUTDEDMoOwAuvYpxSx-XkGqP3qws5t7sJ-dWEpsznq7Byth4-zFv2vsQ4_A2crAHOcrwGjTXXArkYfItaD9X34Z_wnLC6Zkg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67272916</pqid></control><display><type>article</type><title>Oxysterols and neurodegenerative diseases</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Björkhem, Ingemar ; Cedazo-Minguez, Angel ; Leoni, Valerio ; Meaney, Steve</creator><creatorcontrib>Björkhem, Ingemar ; Cedazo-Minguez, Angel ; Leoni, Valerio ; Meaney, Steve</creatorcontrib><description>In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain. The opposite flux of 27-hydroxycholesterol (27-OHC) from the circulation into the brain may regulate a number of key enzymes within the brain.
In vitro experiments suggest that the balance between the levels of these two molecules may be of importance for the generation of β-amyloid peptides. In primary cultures of rat hippocampal cells 27-OHC is able to suppress expression of the activity regulated cytoskeleton-associated protein (Arc), a protein important in memory consolidation which is reduced in patients with Alzheimer’s disease (AD). In the present work we explore the possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia, and discuss the possibility that modification of this flux may be a therapeutic strategy. Lastly, we discuss the use of oxysterols as diagnostic markers in neurodegenerative disease.</description><identifier>ISSN: 0098-2997</identifier><identifier>ISSN: 1872-9452</identifier><identifier>EISSN: 1872-9452</identifier><identifier>DOI: 10.1016/j.mam.2009.02.001</identifier><identifier>PMID: 19248803</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>24S-Hydroxycholesterol ; 27-Hydroxycholesterol ; Activity regulated cytoskeleton-associated protein ; Amyloid beta-Peptides - metabolism ; Blood-Brain Barrier - metabolism ; Blood–brain barrier ; CYP27 ; CYP46 ; Cytoskeletal Proteins - metabolism ; Humans ; Hydroxycholesterols - metabolism ; Medicin och hälsovetenskap ; Nerve Tissue Proteins - metabolism ; Neurodegenerative Diseases - metabolism ; β-Amyloid</subject><ispartof>Molecular aspects of medicine, 2009-06, Vol.30 (3), p.171-179</ispartof><rights>2009 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-5170c2a9f7575fdeb2a43f36c57709d3d244176888501d816d4a840a7691e17a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mam.2009.02.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19248803$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:118942369$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Björkhem, Ingemar</creatorcontrib><creatorcontrib>Cedazo-Minguez, Angel</creatorcontrib><creatorcontrib>Leoni, Valerio</creatorcontrib><creatorcontrib>Meaney, Steve</creatorcontrib><title>Oxysterols and neurodegenerative diseases</title><title>Molecular aspects of medicine</title><addtitle>Mol Aspects Med</addtitle><description>In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain. The opposite flux of 27-hydroxycholesterol (27-OHC) from the circulation into the brain may regulate a number of key enzymes within the brain.
In vitro experiments suggest that the balance between the levels of these two molecules may be of importance for the generation of β-amyloid peptides. In primary cultures of rat hippocampal cells 27-OHC is able to suppress expression of the activity regulated cytoskeleton-associated protein (Arc), a protein important in memory consolidation which is reduced in patients with Alzheimer’s disease (AD). In the present work we explore the possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia, and discuss the possibility that modification of this flux may be a therapeutic strategy. Lastly, we discuss the use of oxysterols as diagnostic markers in neurodegenerative disease.</description><subject>24S-Hydroxycholesterol</subject><subject>27-Hydroxycholesterol</subject><subject>Activity regulated cytoskeleton-associated protein</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Blood–brain barrier</subject><subject>CYP27</subject><subject>CYP46</subject><subject>Cytoskeletal Proteins - metabolism</subject><subject>Humans</subject><subject>Hydroxycholesterols - metabolism</subject><subject>Medicin och hälsovetenskap</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Neurodegenerative Diseases - metabolism</subject><subject>β-Amyloid</subject><issn>0098-2997</issn><issn>1872-9452</issn><issn>1872-9452</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctKxDAUhoMoOl4ewI3MSnDRmpPmiisRbyC40XXINKeScdqOSevl7Y3MqCtdJSTfd0L-n5BDoCVQkKfzsnVtySg1JWUlpbBBJqAVKwwXbJNM8oUumDFqh-ymNM-AUFJskx0wjGtNqwk5uX__SAPGfpGmrvPTDsfYe3zCDqMbwitOfUjoEqZ9stW4RcKD9bpHHq8uHy5uirv769uL87ui5pUZCgGK1syZRgklGo8z5njVVLIWSlHjK884ByW11oKC1yA9d5pTp6QBBOWqPVKs5qY3XI4zu4yhdfHD9i7Y9dFz3qEVwnCmM2_-5Jf5L7_Stwigs1lJk93jlZvBlxHTYNuQalwsXIf9mKxUTDEDMoOwAuvYpxSx-XkGqP3qws5t7sJ-dWEpsznq7Byth4-zFv2vsQ4_A2crAHOcrwGjTXXArkYfItaD9X34Z_wnLC6Zkg</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Björkhem, Ingemar</creator><creator>Cedazo-Minguez, Angel</creator><creator>Leoni, Valerio</creator><creator>Meaney, Steve</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20090601</creationdate><title>Oxysterols and neurodegenerative diseases</title><author>Björkhem, Ingemar ; Cedazo-Minguez, Angel ; Leoni, Valerio ; Meaney, Steve</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-5170c2a9f7575fdeb2a43f36c57709d3d244176888501d816d4a840a7691e17a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>24S-Hydroxycholesterol</topic><topic>27-Hydroxycholesterol</topic><topic>Activity regulated cytoskeleton-associated protein</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Blood–brain barrier</topic><topic>CYP27</topic><topic>CYP46</topic><topic>Cytoskeletal Proteins - metabolism</topic><topic>Humans</topic><topic>Hydroxycholesterols - metabolism</topic><topic>Medicin och hälsovetenskap</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Neurodegenerative Diseases - metabolism</topic><topic>β-Amyloid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Björkhem, Ingemar</creatorcontrib><creatorcontrib>Cedazo-Minguez, Angel</creatorcontrib><creatorcontrib>Leoni, Valerio</creatorcontrib><creatorcontrib>Meaney, Steve</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Molecular aspects of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Björkhem, Ingemar</au><au>Cedazo-Minguez, Angel</au><au>Leoni, Valerio</au><au>Meaney, Steve</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxysterols and neurodegenerative diseases</atitle><jtitle>Molecular aspects of medicine</jtitle><addtitle>Mol Aspects Med</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>30</volume><issue>3</issue><spage>171</spage><epage>179</epage><pages>171-179</pages><issn>0098-2997</issn><issn>1872-9452</issn><eissn>1872-9452</eissn><abstract>In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain. The opposite flux of 27-hydroxycholesterol (27-OHC) from the circulation into the brain may regulate a number of key enzymes within the brain.
In vitro experiments suggest that the balance between the levels of these two molecules may be of importance for the generation of β-amyloid peptides. In primary cultures of rat hippocampal cells 27-OHC is able to suppress expression of the activity regulated cytoskeleton-associated protein (Arc), a protein important in memory consolidation which is reduced in patients with Alzheimer’s disease (AD). In the present work we explore the possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia, and discuss the possibility that modification of this flux may be a therapeutic strategy. Lastly, we discuss the use of oxysterols as diagnostic markers in neurodegenerative disease.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>19248803</pmid><doi>10.1016/j.mam.2009.02.001</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0098-2997 |
ispartof | Molecular aspects of medicine, 2009-06, Vol.30 (3), p.171-179 |
issn | 0098-2997 1872-9452 1872-9452 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_559428 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | 24S-Hydroxycholesterol 27-Hydroxycholesterol Activity regulated cytoskeleton-associated protein Amyloid beta-Peptides - metabolism Blood-Brain Barrier - metabolism Blood–brain barrier CYP27 CYP46 Cytoskeletal Proteins - metabolism Humans Hydroxycholesterols - metabolism Medicin och hälsovetenskap Nerve Tissue Proteins - metabolism Neurodegenerative Diseases - metabolism β-Amyloid |
title | Oxysterols and neurodegenerative diseases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T04%3A31%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxysterols%20and%20neurodegenerative%20diseases&rft.jtitle=Molecular%20aspects%20of%20medicine&rft.au=Bj%C3%B6rkhem,%20Ingemar&rft.date=2009-06-01&rft.volume=30&rft.issue=3&rft.spage=171&rft.epage=179&rft.pages=171-179&rft.issn=0098-2997&rft.eissn=1872-9452&rft_id=info:doi/10.1016/j.mam.2009.02.001&rft_dat=%3Cproquest_swepu%3E67272916%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67272916&rft_id=info:pmid/19248803&rft_els_id=S0098299709000089&rfr_iscdi=true |